Clinical trials
Phase 2 Lymphoma, Mantle-Cell trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2012 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Completed | 3 |
| Terminated | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peter MacCallum Cancer Centre, Australia | 2 |
| Acerta Pharma BV | 1 |
| AstraZeneca | 1 |
| Australasian Leukaemia and Lymphoma Group | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Janssen Research & Development, LLC | 1 |
| National Cancer Institute (NCI) | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Mantle-Cell | 11 |
| Lymphoma | 5 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Blood Protein Disorders | 1 |
| Hematologic Diseases | 1 |
| Immunoproliferative Disorders | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lymphoma, B-Cell | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.